R E V I E W S 47 Massa,P.T., Brinkman, R. and ter Meulen,V. (1987)J. Exp. Med. 166, 259-266 48 Massa,P.T. et al. (1987) Adv. Exp. Med. Biol. 218,203-211 49 Talbot, P.J. et al. (1996) Ann. Neurol. 39, 233-240 50 Watanabe,R., Wege,H. and ter Meulen,V. (1983) Nature 305, 150-152 51 Jouvenne, P. etal. (1992) Virus Res. 22, 125-141 52 Adami,C. et al. (1995) Virology 209, 337-346 53 Parker,S., Gallagher, T. and Buchmeier, M.J. (1989) Virology.' 173, 664-673 54 Banner,L.R.and Lai,M.M. (1991) Virology 185, 441-445 55 Perlman, S. etal. (1987) Microb. Pathog. 2, 185-194 56 Perlman,S. et al. (1990) Virology 175,418-426 57 Pewe,L. et al. (1996) Immunity 5,253-262 58 Perlman,S. and Reis,A. (1987) Microb. Pathog. 3, 309-314 59 Merrill,J.E. et al. (1993)J. Immunol. 151, 2132-2141 60 Selmaj, K.W.and Raine,C.S. (1988) Ann. Neurol. 23, 339-346 61 Selmaj, K.W. et al. (1991)J. Immunol. 147, 1522-1529 62 Cross,A.H.M. et al. (1993)J. Clin. Invest. 93, 2684-2690 63 Boullerne, A.I. et al. (1995) J. Neuroimmunol. 60, 117-124 64 Stohlman, S.A. et al. (1995} J. Virol. 69, 5898-5903 65 Hayashi, M. et al. (1995)J. Neuroimmunol. 60, 143-150 66 Godiska,R. et al. (1995)J. Neuroimmunol. 58, 167-176 Vacc" " " p lses" lnatlon In u . a strategy for global eradication of measles and polio? D. James Nokes and Jonathan Swinton T he global eradication of smallpox, declared in 1979 (Ref. 1), was hoped to be the first in a rapid se- quence of successes in the fight to control the major childhood infectious diseases by vacci- nation. In spite of major achievements in raising global vaccination coverage through routine infant immunization, today it is clear that infections such as measles, poliomyelitis and whooping cough are highly effective adversaries and con- tinue to exact a huge toll in death and disability, particu- larly in the developing world z,3. Recent American successes against poliomyelitis and measles have been attributed to repeated 'pulse' vaccination campaigns. Whilst logistic and economic constraints will be crucial, a deeper epidemiological understanding of the mechanism, strengths and weaknesses of pulse vaccination will optimize the chances of success elsewhere in the world. D.J. Nokes* is in the Dept of Biological Sciences, University of Warwick, CoventD,, UK CV4 7AL; J. Swinton is in the Dept of Plant Sciences, University of Cambridge, Downing Street, Cambridge, UK CB2 3EA. *tel: +44 1203 524 550, fax: +44 1203 524 6•9, e-maik jk@dna.bio.warwick.ac.uk In the light of greater understanding of their epi- demiology and the level of resources and health service infrastructure that are likely to be needed to interrupt transmission, a less-sanguine outlook on our chances of global eradication of these childhood scourges now exists. Theoretical study has identified a level of vac- cination coverage (achieving a 'herd immunity' thresh- old 4,s) above which persistence of infection would be unlikely. The threshold is agent and population spe- cific but generally falls around 80-95% of the popu- lation having vaccine-induced immunity4. Smallpox was something of an outlier, with a predicted thresh- old of nearer 75 % (Ref. 6). Achieving these high levels of coverage represents a daunting task and, in the face of financial, political, motivational and communi- cation difficulties, may not be possible through routine pri- mary health services in many parts of the world. In this context, it is not sur- prising that the achievements of the past decade in Central and South America have become a focus of attention. In 1994, the Americas were declared polio free; the last case recorded was in Peru in 1991 (Ref. 7). Further- more, throughout the Americas reports of measles are at an all- time low, with sights firmly set upon regional elimination with- in the next few years 8. Much of this success has been attrib- uted to the contribution of vaccination campaigns, re- peated at intervals, in which children of a wide age range are offered vaccine 9,1°. Such campaigns, it is reasoned, achieve their effect by rapidly starving the infectious disease of its supply of susceptible individ- uals 1°-12. In a single campaign, a large fraction of the pool of susceptibles in a population may be immunized. The effect is to decrease incidence drastically. In con- trast to this, routine infant immunization procedures only immunize part of each yearly birth cohort; the resultant impact on incidence is slower and less dra- matic. In theory, following a campaign or pulse of vaccine, there is no further need to vaccinate until the susceptible fraction has been restored through births to its original or epidemic threshold13-xq Copyright © 1997 Elsevier Science Ltd. All rights reserved. 0966 842X/97/$17.00 Pll: S0966-842X(96)10079-2 TRENDS IN MICR()BI()I_()GY 14 Vot.. 5 No. I JANUARY 1997